For decades, patent blue dye (PBV) has been utilized for sentinel lymph node biopsy and lymphatic mapping in breast cancer and melanoma staging and treatment. Fistulography and intraoperative display of lymphatic vessels for lymphaticovenular anastomosis (LVA) are frequent applications. Although its anaphylactic potential is well described, PBV is used routinely. We present the case of a 71-year-old female patient, who underwent LVA for the treatment of chronic secondary lymphedema and experienced a postoperative anaphylactic reaction including a blue-colored drug-induced maculopapular exanthema after PBV administration. This article aims to raise awareness of potential life-threatening allergic reactions and propose an alternative to PBV.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961146PMC
http://dx.doi.org/10.7759/cureus.54767DOI Listing

Publication Analysis

Top Keywords

anaphylactic reaction
8
patent blue
8
blue dye
8
lymphaticovenular anastomosis
8
secondary lymphedema
8
reaction patent
4
dye supermicrosurgical
4
supermicrosurgical lymphaticovenular
4
anastomosis treatment
4
treatment secondary
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!